Cagrilintide (5 mg Vial)

This reference covers Cagrilintide (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Cagrilintide (5 mg Vial)

Synonyms/Alias: Cagrilintide

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

This reference covers Cagrilintide (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water β†’ ~ 1.67 mg/mL concentration.

Typical weekly range: 0.6–4.5 mg once weekly (gradual titration over 4–6 weeks).

Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL β‰ˆ 0.0167 mg (16.7 mcg) on a U‑100 insulin syringe.

Storage: Lyophilized: store frozen at βˆ’20 Β°C (βˆ’4 Β°F); after reconstitution, refrigerate at 2–8 Β°C (35.6–46.4 Β°F) and use within 30 days.

Notes

Practical considerations for consistency and tolerability. Use new sterile syringes for each injection; dispose in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) weekly to reduce local irritation. Gradual dose escalation minimizes gastrointestinal side effects such as nausea [4] [6]. Document weekly dose, injection site, and any adverse effects to maintain consistency. For maintenance doses requiring >1.0 mL, ensure you have appropriately sized syringes (3 mL).

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Weeks 1–2
Weekly Dose (mg): 0.6 mg | Units (per injection): 36 units | Volume (mL): 0.36 mL
Weeks 3–4
Weekly Dose (mg): 1.2 mg | Units (per injection): 72 units | Volume (mL): 0.72 mL
Weeks 5–6
Weekly Dose (mg): 2.4 mg | Units (per injection): 144 units | Volume (mL): 1.44 mL
Weeks 7–16 (Maintenance)
Weekly Dose (mg): 4.5 mg | Units (per injection): 270 units | Volume (mL): 2.70 mL
Long-term Storage Conditions
Lyophilized: store frozen at βˆ’20 Β°C (βˆ’4 Β°F); after reconstitution, refrigerate at 2–8 Β°C (35.6–46.4 Β°F) and use within 30 days.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (Cagrilintide, 5 mg each): 8 weeks β‰ˆ 4 vials (17.4 mg total)

12 weeks β‰ˆ 8 vials (35.4 mg total)

16 weeks β‰ˆ 11 vials (53.4 mg total)

Syringes: Weeks 1–4 (doses ≀72 units): U‑100 insulin syringes work well

Weeks 5+ (doses >100 units): 3 mL syringes with 25–27G subcutaneous needles

Per week: 1 syringe

8 weeks: 8 syringes

12 weeks: 12 syringes

16 weeks: 16 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (4 vials): 12 mL β†’ 2 Γ— 10 mL bottles

12 weeks (8 vials): 24 mL β†’ 3 Γ— 10 mL bottles

16 weeks (11 vials): 33 mL β†’ 4 Γ— 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each week. Per week: 2 swabs

8 weeks: 16 swabs

12 weeks: 24 swabs

16 weeks: 32 swabs β†’ recommend 1 Γ— 100‑count box

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China

Related Products

Related Services